Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingmaiyan Granules
- Development stage
- Unknown
- Lead developer
- Shanghai Tufeng Pharmaceutical Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jingmaiyan Granules is a Traditional Chinese Medicine (TCM) candidate developed by Jiangsu Kanion Pharmaceutical and Shanghai Tufeng Pharmaceutical. It is formulated as oral granules intended for the treatment of the acute phase of superficial thrombophlebitis of the limbs, particularly for patients presenting with the blood heat and stasis syndrome (血热瘀结证). The drug aims to clear heat, cool the blood, and resolve blood stasis to reduce inflammation and thrombus formation in superficial veins. It is currently undergoing Phase III clinical trials in China.
- Brand names
- Jingmaiyan Granules
- Other names
- 静脉炎颗粒
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Jingmaiyan Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jingmaiyan Granules.